Gynecological Devices Market Report 2025

The gynecological devices market size has grown strongly in recent years. It will grow from $13.16 billion in 2024 to $14.18 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to introduction of laparoscopic surgery, development of intrauterine devices (IUDs), evolution of hysteroscopy, emergence of robotic surgery, diagnostic imaging advancements.

The gynecological devices market size is expected to see strong growth in the next few years. It will grow to $20.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rise in women's healthcare spending, advancements in robotic surgery, personalized treatment approaches, expanding ambulatory surgical centers. Major trends in the forecast period include minimally invasive procedures, shift towards ambulatory settings, focus on women's health awareness, patient-centric approach, research and development investments.

The rising incidence of gynecological disorders is anticipated to drive the growth of the gynecology devices market in the future. A gynecological disorder refers to a condition that disrupts the normal function of female reproductive organs, including the breasts and abdominal and pelvic organs. Gynecology devices are utilized to manage the female reproductive system, including aspects related to pregnancy and childbirth, and are employed in various medical procedures such as colposcopy, loop electrical excision procedure (LEEP), endometrial biopsy, IUD insertion, dilation and curettage (D&C), tubal ligation, and ovarian cystectomy, among others. For example, in March 2023, a report from the World Health Organization (WHO), a Switzerland-based intergovernmental organization, indicated that endometriosis affects approximately 190 million women and girls of reproductive age worldwide. Additionally, a report from the American Cancer Society, a US-based non-profit organization, projected in January 2023 that around 13,960 new cases of invasive cervical cancer would be diagnosed in 2023, with an estimated 4,310 women expected to face mortality due to cervical cancer during the same period. Consequently, the rising prevalence of gynecological disorders is fueling the growth of the gynecological devices market.

The increasing aging population is likely to enhance the growth of the gynecological devices market in the future. An aging population refers to a demographic trend where a significant proportion or an increasing number of individuals in a population belong to older age groups, typically defined as those aged 65 years or older. This growing aging demographic, characterized by distinct healthcare needs associated with aging, menopause, reproductive health, and age-related gynecological conditions, drives demand for gynecology devices, contributing to the market's growth and development. For instance, a report published by the World Health Organization (WHO) in October 2022 stated that one in six people is expected to be 60 or older by 2030 globally. By 2050, the worldwide population of individuals aged 60 and above is projected to reach 2.1 billion. Therefore, the expanding aging population is propelling the growth of the gynecological devices market.

Technological advancements emerge as a prominent trend in the gynecological devices market, with companies adopting new technologies to maintain their market position. For example, Boston Imaging (Samsung) introduced Hera W10 Elite in February 2023, an artificial intelligence-enabled women's health ultrasound system. This system incorporates advanced features such as the MV-Flow function for visualizing microcirculatory and sluggish blood in 2D and 3D. The platform also includes novel AI aspects such as HeartAssist, ViewAssist, and BiometryAssist, enhancing diagnostic capabilities in obstetrics and gynecology procedures. Technological innovation is a key factor shaping the landscape of the gynecological devices market.

Leading companies in the gynecological devices market are focusing on developing innovative products, such as tissue extraction systems, to cater to a larger customer base, boost sales, and increase revenue. A tissue extraction system is a medical device specifically designed for the removal or extraction of biological tissue during surgical procedures. For example, in September 2022, Olympus Corporation, a Japan-based manufacturer of optical and digital precision technology, introduced the Guardenia Contained Extraction System. The Guardenia system features a unique design aimed at preventing the release of cells into the abdominal cavity during extracorporeal manual morcellation. Its integrated guard not only protects against unintentional damage from sharp surgical instruments near the incision but also exceeds the capabilities of existing devices by providing enhanced incision retraction and covering a larger area of the containment element. The Guardenia system optimizes the space available in the incision, encroaching less while maintaining a stable protective area for manual tissue morcellation. Additionally, the design of the containment bag and guard offers robust protection for both the specimen bag and the incision, distinguishing it from other devices on the market.

In October 2024, Hologic, Inc., a US-based health technology company, acquired Gynesonics for an undisclosed sum. This acquisition aims to enhance Hologic's women's health portfolio by integrating the Sonata System, a minimally invasive, incisionless treatment for uterine fibroids. This expansion is intended to provide more options for gynecological surgeons and improve the quality of life for women experiencing heavy menstrual bleeding. Gynesonics is a US-based medical equipment manufacturer specializing in gynecological devices.

Major companies operating in the gynecological devices market include Medtronic plc, CooperSurgical Inc., Richard Wolf GmbH, Hologic Inc., Boston Scientific Corporation, Stryker Corporation, Karl Storz SE & Co. KG, Ethicon Inc., MedGyn Products Inc., General Electric Company, Gynex Corporation, Bayer AG, Gynemed Medizinprodukte GmbH & Co. KG, Meril Life Sciences Pvt. Ltd., Cook Group Inc., B. Braun Melsungen AG, Siemens Healthineers AG, Smith & Nephew plc, Steris Corporation, Abbott Laboratories, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Medline Industries Inc., Mindray Medical International Limited, Olympus Medical Systems Corporation, Cardinal Health Inc.

North America was the largest region in the gynecological devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gynecological devices market report forecast period. The regions covered in the gynecological devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gynecological devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Gynecological devices encompass instruments specifically designed for the management of the female reproductive system, as well as for childbirth and pregnancy, playing a crucial role in various medical procedures aimed at ensuring the well-being of women.

The primary categories of gynecological devices include surgical devices, diagnostic imaging systems, hand-held instruments, software, and other specialized devices. Surgical devices are instrumental in performing a diverse range of surgical procedures integral to gynecology. These procedures include colposcopy, loop electrical excision, IUD insertion, dilation and curettage (D&C), ovarian cystectomy, tubal ligation, and more. The applications of these devices extend to laparoscopy, hysteroscopy, dilation and curettage, colposcopy, among others, and they find application in clinics, hospitals, diagnostic centers, research institutes, and various healthcare settings.

The gynecological devices market research report is one of a series of new reports that provides gynecological devices market statistics, including gynecological devices industry global market size, regional shares, competitors with a gynecological devices market share, detailed gynecological devices market segments, market trends and opportunities, and any further data you may need to thrive in the gynecological devices industry. The gynecological devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gynecological devices market consists of sales of cesarean forceps, cervical dilators, punch forceps, ultrasound (US) devices, computed tomography (CT) devices, magnetic resonance imaging (MRI) devices, contraceptive devices, fluid management systems, endoscopy devices, and endometrial ablation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.